How stable are Parkinson's disease subtypes in de novo patients: Analysis of the PPMI cohort?

Parkinsonism and Related Disorders

Volumn 28, Issue , 2016, Pages 62-67

  Simuni, Tanya ^a   Caspell Garcia, Chelsea ^b   Coffey, Christopher ^b   Lasch, Shirley ^c   Tanner, Caroline ^d   Marek, Ken ^c  

^a NORTHWESTERN UNIVERSITY   (United States)

^b UNIVERSITY OF IOWA   (United States)

^c INSTITUTE FOR NEURODEGENERATIVE DISORDERS   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Disease subtypes; Gait disorder predominant; Parkinson's disease; Postural instability; Tremor dominant

Indexed keywords

SELEGILINE; TOCOPHEROL;

ADULT; AGED; ARTICLE; BRADYKINESIA; CASE CONTROL STUDY; COHORT ANALYSIS; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; DIFFERENTIAL DIAGNOSIS; DISEASE CLASSIFICATION; ETHNICITY; FEMALE; HUMAN; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; PARKINSON DISEASE; POSTURAL INSTABILITY GAIT DISORDER DOMINANT PARKINSON DISEASE; PREDICTIVE VALUE; PRIORITY JOURNAL; PROGNOSIS; RIGIDITY; SENSITIVITY AND SPECIFICITY; TREMOR; TREMOR DOMINANT PARKINSON DISEASE; UNIFIED PARKINSON DISEASE RATING SCALE; CLASSIFICATION; COMPLICATION; MIDDLE AGED; NEUROLOGIC GAIT DISORDER; PATHOPHYSIOLOGY; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; CASE-CONTROL STUDIES; FEMALE; GAIT DISORDERS, NEUROLOGIC; HUMANS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; PARKINSON DISEASE; TREMOR;

EID: 84964592964     PISSN: 13538020     EISSN: 18735126     Source Type: Journal    
DOI: 10.1016/j.parkreldis.2016.04.027     Document Type: Article

References (19)

1. Hughes A.J., et al. What features improve the accuracy of clinical diagnosis in Parkinson's disease: a clinicopathologic study. Neurology 1992, 42(6):1142-1146.
2. Ward C.D., Gibb W.R. Research diagnostic criteria for Parkinson's disease. Adv. Neurol. 1990, 53:245-249.
3. Calne D.B. Is "Parkinson's disease" one disease?. J. Neurol. Neurosurg. Psychiatry 1989, (Suppl):18-21.
4. Jankovic J., et al. Variable expression of Parkinson's disease: a base-line analysis of the DATATOP cohort. Neurology 1990, 40(10):1529-1534. The Parkinson Study Group.
5. McDermott M.P., et al. Factors predictive of the need for levodopa therapy in early, untreated Parkinson's disease. Arch. Neurol. 1995, 52(6):565-570. The Parkinson Study Group.
6. Hershey L.A., et al. Tremor at onset. Predictor of cognitive and motor outcome in Parkinson's disease?. Arch. Neurol. 1991, 48(10):1049-1051.
7. Rajput A.H., et al. Prognostic significance of the onset mode in parkinsonism. Neurology 1993, 43(4):829-830.
8. Jankovic J., Kapadia A.S. Functional decline in Parkinson disease. Arch. Neurol. 2001, 58(10):1611-1615.
9. Post B., et al. Prognostic factors for the progression of Parkinson's disease: a systematic review. Mov. Disord. 2007, 22(13):1839-1851. quiz 1988.
10. The Parkinson progression marker initiative (PPMI). Prog. Neurobiol. 2011, 95(4):629-635.
11. Goetz C.G. Movement disorder society-unified Parkinson's disease rating scale (MDS-UPDRS): a new scale for the evaluation of Parkinson's disease. Rev. Neurol. 2010, 166(1):1-4. (Paris).
12. Stebbins G.T., et al. How to identify tremor dominant and postural instability/gait difficulty groups with the movement disorder society unified Parkinson's disease rating scale: comparison with the unified Parkinson's disease rating scale. Mov. Disord. 2013, 28(5):668-670.
13. Effect of deprenyl on the progression of disability in early Parkinson's disease. N. Engl. J. Med. 1989, 321(20):1364-1371. The Parkinson Study Group.
14. Goetz C.G., Stebbins G.T., Tilley B.C. Calibration of unified Parkinson's disease rating scale scores to Movement Disorder Society-unified Parkinson's disease rating scale scores. Mov. Disord. 2012, 27(10):1239-1242.
15. Langston J.W., et al. Core assessment program for intracerebral transplantations (CAPIT). Mov. Disord. 1992, 7(1):2-13.
16. Anderson E., Nutt J. The long-duration response to levodopa: phenomenology, potential mechanisms and clinical implications. Park. Relat. Disord. 2011, 17(8):587-592.
17. Suchowersky O., et al. Practice parameter: diagnosis and prognosis of new onset Parkinson disease (an evidence-based review): report of the quality standards subcommittee of the American Academy of Neurology. Neurology 2006, 66(7):968-975.
18. Kang J.H., et al. Association of cerebrospinal fluid beta-amyloid 1-42, T-tau, P-tau181, and alpha-synuclein levels with clinical features of drug-naive patients with early Parkinson disease. JAMA Neurol. 2013, 70(10):1277-1287.
19. Pont-Sunyer C., et al. The onset of nonmotor symptoms in Parkinson's disease (the ONSET PD study). Mov. Disord. 2015, 30(2):229-237.